Vemurafenib (INN), sold under the brand name Zelboraf, is a medication used for the treatment of late-stage melanoma. It is an inhibitor of the B-Raf enzyme and was developed by Plexxikon.
via Wikipedia infobox
{{Infobox drug | IUPAC_name = N-(3-{[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide | verifiedrevid = 432742697 | image = Vemurafenib structure.svg | image_class = skin-invert-image | image2 = Vemurafenib ball-and-stick model.png | image_class2 = bg-transparent | width = 230
| pronounce = | tradename = Zelboraf | Drugs.com = | MedlinePlus = a612009 | licence_EU = yes | licence_US = Vemurafenib | pregnancy_AU = D | pregnancy_AU_comment = | routes_of_administration = By mouth | ATC_prefix = L01 | ATC_suffix = XE15
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).